Literature DB >> 12725869

Regulation of muscarinic acetylcholine receptor signaling.

Chris J van Koppen1, Björn Kaiser.   

Abstract

Multiple mechanisms regulate the signaling of the five members of the family of the guanine nucleotide binding protein (G protein)-coupled muscarinic acetylcholine (ACh) receptors (mAChRs). Following activation by classical or allosteric agonists, mAChRs can be phosphorylated by a variety of receptor kinases and second messenger-regulated kinases. The phosphorylated mAChR subtypes can interact with beta-arrestin and presumably other adaptor proteins as well. As a result, the various mAChR signaling pathways may be differentially altered, leading to short-term or long-term desensitization of a particular signaling pathway, receptor-mediated activation of the mitogen-activated protein kinase pathway downstream of mAChR phosphorylation, as well as long-term potentiation of mAChR-mediated phospholipase C stimulation. Agonist activation of mAChRs may also induce receptor internalization and down-regulation, which proceed in a highly regulated manner, depending on receptor subtype and cell type. In this review, our current understanding of the complex regulatory processes that underlie signaling of mAChR is summarized.

Mesh:

Substances:

Year:  2003        PMID: 12725869     DOI: 10.1016/s0163-7258(03)00032-9

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  50 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

2.  Probing novel GPCR interactions using a combination of FRET and TIRF.

Authors:  Stephanie B Boyer; Paul A Slesinger
Journal:  Commun Integr Biol       Date:  2010-07

3.  Why does the agonist [(18)F]FP-TZTP bind preferentially to the M(2) muscarinic receptor?

Authors:  L Ravasi; D O Kiesewetter; K Shimoji; G Lucignani; W C Eckelman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12-07       Impact factor: 9.236

4.  Agonist-induced internalization of the Caenorhabditis elegans muscarinic acetylcholine receptor GAR-3 in Chinese hamster ovary cells.

Authors:  Boram Choi; Yang-Seo Park; Nam Jeong Cho
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

5.  The internalization of the M2 and M4 muscarinic acetylcholine receptors involves distinct subsets of small G-proteins.

Authors:  Cindy Reiner; Neil M Nathanson
Journal:  Life Sci       Date:  2008-01-29       Impact factor: 5.037

6.  Contrasting effects of allosteric and orthosteric agonists on m1 muscarinic acetylcholine receptor internalization and down-regulation.

Authors:  Rachel L Thomas; Christopher J Langmead; Martyn D Wood; R A John Challiss
Journal:  J Pharmacol Exp Ther       Date:  2009-09-18       Impact factor: 4.030

7.  In vivo long-term synaptic plasticity of glial cells.

Authors:  Eve-Lyne Bélair; Joanne Vallée; Richard Robitaille
Journal:  J Physiol       Date:  2010-02-08       Impact factor: 5.182

8.  Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein.

Authors:  Takeshi Soeki; Toshiyuki Niki; Etsuko Uematsu; Sachiko Bando; Tomomi Matsuura; Kenya Kusunose; Takayuki Ise; Yuka Ueda; Noriko Tomita; Koji Yamaguchi; Kunihiko Koshiba; Shusuke Yagi; Daiju Fukuda; Yoshio Taketani; Takashi Iwase; Hirotsugu Yamada; Tetsuzo Wakatsuki; Masashi Akaike; Michio Shimabukuro; Ichiro Kishimoto; Kenji Kangawa; Masataka Sata
Journal:  Heart Vessels       Date:  2013-03-15       Impact factor: 2.037

9.  Direct interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling.

Authors:  Stephanie B Boyer; Sinead M Clancy; Miho Terunuma; Raquel Revilla-Sanchez; Steven M Thomas; Stephen J Moss; Paul A Slesinger
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

10.  Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003.

Authors:  M P Montgomery; F Kamel; T M Saldana; M C R Alavanja; D P Sandler
Journal:  Am J Epidemiol       Date:  2008-03-14       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.